Tower Research Capital (TRC)’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,096
| Closed | -$6.19K | – | 5990 |
|
|
2024
Q4 | $6.19K | Buy |
3,096
+1,356
| +78% | +$2.71K | ﹤0.01% | 4196 |
|
|
2024
Q3 | $4.33K | Sell |
1,740
-1,465
| -46% | -$3.65K | ﹤0.01% | 4585 |
|
|
2024
Q2 | $11.2K | Buy |
3,205
+3,087
| +2,616% | +$10.8K | ﹤0.01% | 4098 |
|
|
2024
Q1 | $1.31K | Buy |
118
+27
| +30% | +$300 | ﹤0.01% | 5283 |
|
|
2023
Q4 | $1.1K | Sell |
91
-1
| -1% | -$12 | ﹤0.01% | 5435 |
|
|
2023
Q3 | $4.86K | Buy |
92
+17
| +23% | +$898 | ﹤0.01% | 4804 |
|
|
2023
Q2 | $6.59K | Sell |
75
-32
| -30% | -$2.81K | ﹤0.01% | 4657 |
|
|
2023
Q1 | $9K | Buy |
+107
| New | +$9K | ﹤0.01% | 4564 |
|
|
2022
Q4 | – | Sell |
-19
| Closed | -$14K | – | 6484 |
|
|
2022
Q3 | $14K | Buy |
19
+16
| +533% | +$11.8K | ﹤0.01% | 4232 |
|
|
2022
Q2 | $1K | Sell |
3
-26
| -90% | -$8.67K | ﹤0.01% | 5884 |
|
|
2022
Q1 | $15K | Buy |
29
+10
| +53% | +$5.17K | ﹤0.01% | 3845 |
|
|
2021
Q4 | $19K | Buy |
19
+4
| +27% | +$4K | ﹤0.01% | 3752 |
|
|
2021
Q3 | $25K | Buy |
15
+5
| +50% | +$8.33K | ﹤0.01% | 3538 |
|
|
2021
Q2 | $29K | Buy |
10
+8
| +400% | +$23.2K | ﹤0.01% | 3542 |
|
|
2021
Q1 | $17K | Sell |
2
-5
| -71% | -$42.5K | ﹤0.01% | 4021 |
|
|
2020
Q4 | $49K | Buy |
7
+1
| +17% | +$7K | ﹤0.01% | 3152 |
|
|
2020
Q3 | $75K | Buy |
6
+2
| +50% | +$25K | ﹤0.01% | 3357 |
|
|
2020
Q2 | $52K | Buy |
+4
| New | +$52K | ﹤0.01% | 3017 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2870 |
|
|
2019
Q2 | – | Hold |
0
| – | -$2K | – | 4419 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3478 |
|
|
2018
Q3 | – | Sell |
-1
| Closed | -$2K | – | 4329 |
|
|
2018
Q2 | $2K | Buy |
+1
| New | +$2K | ﹤0.01% | 3394 |
|
|
2017
Q4 | – | Sell |
-7
| Closed | -$41K | – | 4206 |
|
|
2017
Q3 | $41K | Buy |
+7
| New | +$41K | ﹤0.01% | 2156 |
|